Company intelligence / Profile preview

IONLACE

Stockholm, Stockholm County, Swedenlinkedin.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

IONLACE specializes in developing next-generation biotech tools that leverage artificial intelligence and synthetic biology. The company aims to create innovative solutions for real-time health status monitoring and global health impact. No clinical results are reported as the focus appears to be on enabling technologies rather than direct therapeutics.

Modalities: Synthetic biology toolsmachine learning platforms (specific therapeutic modalities not detailed)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on IONLACE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IONLACE.

Explore the full profile